Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ernexa Therapeutics (ERNA) Interest Coverage Ratio (2022 - 2023)

Historic Interest Coverage Ratio for Ernexa Therapeutics (ERNA) over the last 2 years, with Q4 2023 value amounting to 23.53.

  • Ernexa Therapeutics' Interest Coverage Ratio fell 66429.76% to 23.53 in Q4 2023 from the same period last year, while for Sep 2024 it was 76.5, marking a year-over-year decrease of 39142.8%. This contributed to the annual value of 34.42 for FY2023, which is 9689.12% up from last year.
  • Latest data reveals that Ernexa Therapeutics reported Interest Coverage Ratio of 23.53 as of Q4 2023, which was down 66429.76% from 48.29 recorded in Q3 2023.
  • Over the past 5 years, Ernexa Therapeutics' Interest Coverage Ratio peaked at 4.17 during Q4 2022, and registered a low of 991.43 during Q2 2022.